The prevalence of antibodies to human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), human T lymphotropic virus I (HTLV-I), and hepatitis B (HBV) surface antigen (HBsAg) was determined in blood donors from Ntcheu, Malawi. Each donation was also screened for HIV-1 RNA and HCV RNA. Am
Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors
โ Scribed by H.A. Sulaiman; Julitasari; Annie Sie; Masri Rustam; W. Melani; A. Corwin; G.B. Jennings
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 522 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
An enzyme immunoassay (EIA) was developed in-house for the detection of anti-hepatitis C virus (HCV) antibody against the prevailing genotypes in India. The specific reactivity of the test was compared with commercial second and third-generation EIAs and reverse transcription nested polymerase chain
To determine the current incidence of hepatitis B core antibody (anti-HBc) in a healthy blood donor population, 1,893 donors were screened for anti-HBc. Forty-one (2.16%) were found to be initially positive and 35 (1.85%) repeatably positive. Sera from the repeatably positive donors were further scr
The seroprevalence of hepatitis C virus was evaluated in blood donors and antenatal clinic attenders in Kumasi, Ghana and seropositive subjects were tested for hepatitis C virus ribonucleic acid by the polymerase chain reaction (PCR).The overall seroprevalence among Ghanaians was 2.8% but there was